Totally Implantable Venous Access Port Systems: Implant Depth-based Complications in Breast Cancer Therapy - A Comparative Study

CONCLUSION: Subcutaneous implantation of TIVAPS at a depth of 8-12 mm could be preferred due to the lowest incidence of internal and external complications compared to the incidence of these complications in other groups; this depth could be referred to as the safe and convenient implantation depth for the effective delivery of chemotherapy regimen in BC patients without difficulty in transcutaneous access to the port.PMID:34488584 | DOI:10.2174/1381612827666210901170522

Source: Current Pharmaceutical Design - September 7, 2021 Category: Drugs & Pharmacology Authors: Kuo Chen Narasimha M Beeraka Yuanting Gu Jingruo Li Mikhail Sinelnikov Nan Han Pengwei Lu Source Type: research